Announced details
Treatment of full-thickness and partial-thickness wounds, particularly wounds that do not respond to existing treatments, including hard-to-heal and chronic wounds.
In October 2024, 科研製薬 entered into a licensing agreement with SANYO CHEMICAL INDUSTRIES,LTD. for the exclusive sales rights to this product in Japan.
Head office: Higashiyama-ku, Kyoto, Kyoto Prefecture. President: Harada Masahiro (原田正大). Founded in 1949, the company manufactures and markets functional chemicals. It handles more than 3,000 products in Japan and overseas, supplying products for applications including automobiles, electronic equipment, cosmetics and medical devices.
Approval number: 30700BZX00089000. Manufacturing and marketing approval date: 21 April 2025. Validity period: Not disclosed.
Reimbursement price: ¥1,460 per 1 cm²
The company does not address Contract Value / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Silk Elastin Wound Sheet |
| Counterparty | SANYO CHEMICAL INDUSTRIES,LTD. |
| Counterparty overview | Head office: Higashiyama-ku, Kyoto, Kyoto Prefecture. President: Harada Masahiro (原田正大). Founded in 1949, the company manufactures and markets functional chemicals. It handles more than 3,000 products in Japan and overseas, supplying products for applications including automobiles, electronic equipment, cosmetics and medical devices. |
| Relationship with the Company | In October 2024, 科研製薬 entered into a licensing agreement with SANYO CHEMICAL INDUSTRIES,LTD. for the exclusive sales rights to this product in Japan. |
| Offering price | Reimbursement price: ¥1,460 per 1 cm² |
| Contract Date | October 2024 |
| Launch date | Public health insurance coverage start date: 1 June 2026. Preparations for the launch are under way; launch date: Not disclosed. |
| Applicable area | Treatment of full-thickness and partial-thickness wounds, particularly wounds that do not respond to existing treatments, including hard-to-heal and chronic wounds. |
| Registration number and expiry date | Approval number: 30700BZX00089000. Manufacturing and marketing approval date: 21 April 2025. Validity period: Not disclosed. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company aims to make this product available to patients as a new treatment option for wounds, including chronic and hard-to-heal wounds, and to contribute to improved quality of life.